Zobrazeno 1 - 10
of 33 804
pro vyhledávání: '"Thiotepa"'
Autor:
Mora E; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain. mora_elv@gva.es.; Instituto de Investigación Sanitaria La Fe, Valencia, Spain. mora_elv@gva.es., Montoro J; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Balaguer A; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Instituto de Investigación Sanitaria La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain., Rovira M; BMT Unit. Hematology Department, ICMHO, Hospital Clínic, Institut Josep Carreras contra la leucemia, Barcelona, Spain., Cabrero M; Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomedica de Salamanca-IBSAL, Salamanca, Spain., Heras I; Hematology Department, Hospital General Universitario Morales Meseguer, Murcia, Spain., Ribera JM; Hematology Department. Institut Català d'Oncologia - Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Spain.; Department of Medicine, Universidad Autónoma de Barcelona, Badalona, Spain., Antelo G; Radiation Oncology Department, ICMHO, Hospital Clínic, Barcelona, Spain., Martin AA; Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomedica de Salamanca-IBSAL, Salamanca, Spain., Lopez Godino O; Hematology Department, Hospital General Universitario Morales Meseguer, Murcia, Spain., Torrent A; Hematology Department. Institut Català d'Oncologia - Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Spain., Villalba M; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Chorao P; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Sanz MA; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Instituto de Investigación Sanitaria La Fe, Valencia, Spain.; Department of Medicine, University of Valencia, Valencia, Spain., Sanz J; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Instituto de Investigación Sanitaria La Fe, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain.; Department of Medicine, University of Valencia, Valencia, Spain.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2024 Aug; Vol. 59 (8), pp. 1137-1145. Date of Electronic Publication: 2024 May 16.
Autor:
Higham CS; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California. Electronic address: christine.higham@ucsf.edu., Shimano KA; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California; Division of Pediatric Hematology, University of California San Francisco, Benioff Children's Hospital, San Francisco, California., Kharbanda S; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California., Chu J; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California., Cisneros GS; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California., Winestone LE; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California., Dara J; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California., Huang JN; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California; Division of Pediatric Hematology, University of California San Francisco, Benioff Children's Hospital, San Francisco, California., Hermiston ML; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California; Division of Pediatric Oncology, University of California San Francisco, Benioff Children's Hospital, San Francisco, California., Long-Boyle JR; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California; Department of Clinical Pharmacy, University of California San Francisco, Benioff Children's Hospital, San Francisco, California., Dvorak CC; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplant, University of California San Francisco, Benioff Children's Hospitals, San Francisco, California.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Sep; Vol. 30 (9), pp. 931.e1-931.e10. Date of Electronic Publication: 2024 Jun 27.
Autor:
Shadur B; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Medical Centre, Jerusalem, Israel. bella.shadur@gmail.com.; Garvan Institute of Medical Research, Sydney, Australia. bella.shadur@gmail.com.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia. bella.shadur@gmail.com., NasserEddin A; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Medical Centre, Jerusalem, Israel., Zaidman I; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Medical Centre, Jerusalem, Israel., Schejter YD; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Medical Centre, Jerusalem, Israel., Even-Or E; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Medical Centre, Jerusalem, Israel., Berkun Y; Department of General Paediatrics, Hadassah University Medical Centre, Jerusalem, Israel., Meyts I; Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.; Pediatric Immunodeficiency, Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium., Hmedat H; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Medical Centre, Jerusalem, Israel., Sulaiman A; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Medical Centre, Jerusalem, Israel., Tangye SG; Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia., Stepensky P; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Medical Centre, Jerusalem, Israel.
Publikováno v:
Journal of clinical immunology [J Clin Immunol] 2024 Sep 12; Vol. 45 (1), pp. 3. Date of Electronic Publication: 2024 Sep 12.
Autor:
Jamison T; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Haque E; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia., Muhsen IN; Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Samarkandi H; Oncology Pharmacy Services, Faisal Specialist Hospital and Research Center, Riyadh, King, Saudi Arabia., Fakih RE; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.; Transplantation and Cellular Therapy Section, Oncology Center, King Faisal Specialist Hospital and Research Center, 11211, Riyadh, Saudi Arabia., Aljurf M; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. maljurf@kfshrc.edu.sa.; Transplantation and Cellular Therapy Section, Oncology Center, King Faisal Specialist Hospital and Research Center, 11211, Riyadh, Saudi Arabia. maljurf@kfshrc.edu.sa.
Publikováno v:
Medical oncology (Northwood, London, England) [Med Oncol] 2024 Jun 17; Vol. 41 (7), pp. 177. Date of Electronic Publication: 2024 Jun 17.
Autor:
Huang X; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China., Wang S; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China., Xu Y; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China., Mei C; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China., Han Q; Department of Pathology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China., Wu X; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China., Du F; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China., Ren Y; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China., Jin J; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China. jiej0503@zju.edu.cn.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China. jiej0503@zju.edu.cn., Tong H; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China. tonghongyan@zju.edu.cn.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China. tonghongyan@zju.edu.cn., Qian J; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, No. 366 Wutong Road, Hangzhou, China. jiejingq@aliyun.com.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China. jiejingq@aliyun.com.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Jun; Vol. 103 (6), pp. 2165-2168. Date of Electronic Publication: 2024 Apr 08.
Autor:
Altundag K; MKA Breast Cancer Clinic, Tepe Prime, 06800, Cankaya, Ankara, Turkey. altundag66@yahoo.com.
Publikováno v:
Medical oncology (Northwood, London, England) [Med Oncol] 2024 Jun 29; Vol. 41 (8), pp. 189. Date of Electronic Publication: 2024 Jun 29.
Autor:
Schofield RC; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scordo M; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Shah G; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Carlow DC; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. carlowd@mskcc.org.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2737, pp. 423-433.
Autor:
Loison, Rebecca1, Abbar, Baptiste2 baptiste.abbar@gmail.com, Drouin, Leonor1, Bonnet-Bensimon, Charlotte1, Cuvier, Caroline1, Giacchetti, Sylvie1, Espie, Marc1, Teixeira, Luis1, De Castelbajac, Victoire1
Publikováno v:
Acta Oncologica. Dec2023, Vol. 62 Issue 12, p1961-1966. 6p.
Autor:
Yufeng Li1,2, Yajun Li1, Ruolan Zeng1, Yizi He1, Liang Liang1, Lijia Ou2, Chang Su2, Hui Zhou1 zhouhui9403@126.com, Ling Xiao2 xiaolingcsu@csu.edu.cn
Publikováno v:
Journal of Cancer. 2023, Vol. 14 Issue 17, p3182-3190. 9p.
Autor:
Linxweiler, Helen1 (AUTHOR) helen.linxweiler@unimedizin-mainz.de, Thiesen, Judith1 (AUTHOR), Krämer, Irene1 (AUTHOR)
Publikováno v:
Pharmaceutics. Feb2023, Vol. 15 Issue 2, p309. 16p.